CRA International stock gave back 4.1% the day after posting what management called record second quarter results. That gap between a softer share price and stronger reported fundamentals is the story investors need to unpack.

CRA International booked revenue of US$210.8m for Q2, the highest quarterly level in its history, with basic earnings per share of US$2.13. The company also flagged record first half non GAAP earnings before interest, tax, depreciation and amortization. The full picture now hinges on how investors weigh that growth against valuation, leverage and cash flow, which will be explored next.

Impressed by CRA International's record quarterly revenue but unsure how to balance that against valuation and balance sheet risk? Check out our list of solid balance sheet and fundamentals stocks (49 results).

Q2 2026 Earnings Summary

• Revenue (Q2 2026 vs. Q2 2025): US$210.8m vs. US$186.9m (up about 12.8% year on year, a new quarterly record for CRA International)
• Net Income (Q2 2026 vs. Q2 2025): US$13.5m vs. US$12.1m (modest growth in underlying profit excluding extra items)
• Basic EPS (Q2 2026 vs. Q2 2025): US$2.13 vs. US$1.81 (higher earnings per share on a quarterly basis)
• Non GAAP EBITDA Margin (H1 2026 vs. H1 2025): 12.2% on revenue of US$408.8m vs. prior year first half margin of 16.3% and non GAAP SG&A (selling, general and administrative) as a share of revenue (lower overhead ratio supports profitability even with higher talent investment)

Prefer clean charts instead of a dense wall of earnings figures and margin percentages? See CRA International's full financial picture with a visual breakdown of its valuation in the company report for CRA International.

CRA International bulls focus on scale and pricing power

The optimistic story around CRA International is that specialist expertise and investment in senior talent will support larger, higher margin mandates and pricing power. The quarter does validate parts of that claim. Revenue reached a record US$210.8m and first half non GAAP EBITDA was US$49.7m, helped by 77% utilization and consultant headcount up 3.3% to 968. Eight practices grew year on year and international revenue rose 32.9%, which points to strong demand for the specialist bench. Non GAAP SG&A fell to 15.5% of revenue from 16.3%, which supports the idea that the model can add talent while keeping overhead efficient. At the same time, the first half non GAAP EBITDA margin of 12.2% sits below the prior year first half, so the margin expansion part of the bull story is not yet fully in place.

Bears focus on margins, concentration and leverage risk

The cautious view is that CRA International is overexposed to cyclical antitrust and M&A work, faces rising compensation, and is leaning harder on debt funded buybacks. This quarter gives that camp mixed results. Antitrust, Life Sciences, Energy and Forensics all posted strong growth, and management again called out broad based demand, which works against fears of an imminent revenue air pocket. However, non GAAP EBITDA margin for the first half is 12.2% versus 16.3% a year earlier while noncash forgivable loan amortization is set to rise about US$15m in fiscal 2026, showing clear cost pressure from talent investments. Net debt stands near US$197.6m and the company returned US$31.4m to shareholders in Q2, with buybacks funded partly from a revolver that now extends to US$400m. That supports concerns around financial flexibility if growth or utilization soften.

Compare CRA International's record revenue, softer first half margins and share price pullback with how the street is recalibrating expectations. See the consensus price target analysis for CRA International to check where analysts currently stand on NasdaqGS:CRAI.

Stay Ahead With CRA International Insights

If CRA International's record revenue and recent share price pullback have caught your attention, register for free with Simply Wall St and add it to your Watchlist to track price against fair value and watch for a more attractive entry point. Once you own the stock, keep your decisions focused with the Portfolio Command Center that surfaces the key updates and fundamentals that matter most to your holdings. For a longer term view, use the Community to see how other investors are thinking about CRA International and similar opportunities. This way you can spot potential catalysts and risks early and stay a step ahead of the market.

Seeking Alternatives Beyond CRA International?

Fresh ideas can move fast as momentum builds and early breakouts get caught by the crowd. Scan these under the radar for now opportunities while it matters and act now.

• Target resilient income streams before yields get compressed by demand and rising prices by checking out carefully screened 8 dividend fortresses that balance payouts with solid fundamentals.
• Spot future growth stories while they are still flying under most radars by reviewing the curated 19 high quality undiscovered gems that pair quality metrics with cleaner balance sheets.
• Track the companies building the backbone of AI growth before valuations move away from you by scanning the focused 55 AI infrastructure stocks set of enablers powering the trend.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.